We are utilizing our Probody® platform to develop potential best-in-class therapies against clinically validated targets and potential first-in-class therapeutics against novel, difficult-to-treat targets.
We believe our Probody therapeutics have the potential to:
- Create or widen therapeutic window – the balance between a therapy’s dose that is effective without causing unacceptable toxicity
- Enable new combinations of drugs previously not possible due to toxicities
- Expand the universe of viable therapeutic targets by opening “undruggable” target space
- Make new treatment options possible for more patients